Healthways, Inc. (NASDAQ:TVTY) has received an average recommendation of “Buy” from the ten analysts that are currently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $40.14.

A number of brokerages have recently issued reports on TVTY. Chardan Capital began coverage on shares of Healthways in a research report on Tuesday. They set a “neutral” rating and a $40.00 target price on the stock. ValuEngine upgraded shares of Healthways from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd. Zacks Investment Research lowered shares of Healthways from a “buy” rating to a “hold” rating in a research report on Tuesday, August 1st. Jefferies Group LLC restated a “buy” rating and set a $36.00 target price on shares of Healthways in a research report on Friday, June 16th. Finally, Cantor Fitzgerald raised their target price on shares of Healthways from $34.00 to $42.00 and gave the stock an “overweight” rating in a research report on Friday, June 9th.

Shares of Healthways (TVTY) traded down 1.53% during mid-day trading on Tuesday, reaching $38.60. 214,407 shares of the company’s stock traded hands. The firm has a market cap of $1.52 billion, a price-to-earnings ratio of 17.39 and a beta of 0.37. The firm’s 50-day moving average is $38.50 and its 200 day moving average is $33.74. Healthways has a one year low of $19.25 and a one year high of $41.55.

Healthways (NASDAQ:TVTY) last announced its earnings results on Thursday, July 27th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.03. The business had revenue of $138.90 million for the quarter, compared to analyst estimates of $138.15 million. Healthways had a net margin of 17.30% and a return on equity of 29.81%. The firm’s revenue for the quarter was up 11.1% on a year-over-year basis. Analysts predict that Healthways will post $1.53 earnings per share for the current year.

In other Healthways news, insider Mary Flipse sold 1,340 shares of the firm’s stock in a transaction on Friday, August 11th. The stock was sold at an average price of $37.32, for a total value of $50,008.80. Following the completion of the sale, the insider now owns 75,187 shares of the company’s stock, valued at $2,805,978.84. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Conan Laughlin sold 1,750,000 shares of the firm’s stock in a transaction on Tuesday, August 1st. The shares were sold at an average price of $37.90, for a total value of $66,325,000.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 1,809,913 shares of company stock valued at $68,582,025. Corporate insiders own 8.42% of the company’s stock.

A number of large investors have recently added to or reduced their stakes in the stock. Lord Abbett & CO. LLC increased its stake in Healthways by 158.7% in the second quarter. Lord Abbett & CO. LLC now owns 745,372 shares of the company’s stock worth $29,704,000 after buying an additional 457,285 shares during the period. Piedmont Investment Advisors LLC acquired a new stake in Healthways during the second quarter worth approximately $290,000. Flinton Capital Management LLC increased its stake in Healthways by 63.5% in the second quarter. Flinton Capital Management LLC now owns 3,502 shares of the company’s stock worth $139,000 after buying an additional 1,360 shares during the period. Riverhead Capital Management LLC increased its stake in Healthways by 69.7% in the second quarter. Riverhead Capital Management LLC now owns 3,564 shares of the company’s stock worth $142,000 after buying an additional 1,464 shares during the period. Finally, Eaton Vance Management acquired a new stake in Healthways during the second quarter worth approximately $625,000.

WARNING: This piece was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of US & international copyright legislation. The original version of this piece can be read at https://www.thecerbatgem.com/2017/09/01/healthways-inc-tvty-receives-40-14-consensus-pt-from-analysts.html.

Healthways Company Profile

Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.

Analyst Recommendations for Healthways (NASDAQ:TVTY)

Receive News & Stock Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related stocks with our FREE daily email newsletter.